23 results
8-K
EX-10.1
MACA
Moringa Acquisition Corp
21 Aug 24
Silexion Therapeutics Ltd. and Moringa Acquisition Corp Announce Closing of their Business Combination
4:05pm
406 of the Employee Retirement Income Security Act of 1974, as amended, Section 4975 of the Internal Revenue Code of 1986, as amended, or any … of the Employee Retirement Income Security Act of 1974, if the investment decision is being made by a plan fiduciary, as defined in Section 3(21
8-K
EX-3.1
MACA
Moringa Acquisition Corp
21 Aug 24
Silexion Therapeutics Ltd. and Moringa Acquisition Corp Announce Closing of their Business Combination
4:05pm
on behalf of the Company may pay a gratuity or pension or allowance on retirement to any Director who has held any other salaried office or place of profit
DEFM14A
MACA
Moringa Acquisition Corp
17 Jul 24
Proxy related to merger
9:13am
by it, has agreed in the Business Combination Agreement to forfeit, for retirement, all 2,875,000 Moringa founders shares at the Closing. However, up … to 1,567,000 Moringa founders shares designated for forfeiture may, in lieu of forfeiture and retirement, be transferred by the Sponsor (upon the agreement
8-K
EX-10.2
MACA
Moringa Acquisition Corp
3 Apr 24
Entry into a Material Definitive Agreement
11:22am
surrender to TopCo for retirement (i) eight thousand (8,000) TopCo Shares, and (ii) for every $1,000 deficiency from that $500,000 amount, up … any 30-trading day period. (e) Effective as of immediately prior to the Closing, SPAC Sponsor shall surrender to the SPAC for retirement all
8-K
MACA
Moringa Acquisition Corp
3 Apr 24
Entry into a Material Definitive Agreement
11:22am
occurred since the date of the Silexion Business Combination Agreement; (iv) the forfeiture by the SPAC Sponsor for retirement of all 2,875,000 SPAC … , the SPAC Sponsor shall surrender for retirement (x) 8,000 TopCo Shares and (y) for every $1,000 deficiency from that $500,000 amount, up to a maximum
8-K
EX-2.1
i1nswtzcog7 hq
3 Apr 24
Entry into a Material Definitive Agreement
11:22am
8-K
EX-2.1
y7w2rkyywv 14
26 Feb 24
Silexion, a Clinical-Stage, Oncology-Focused Biotechnology Company, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp
5:29pm
8-K
2e47k
26 Feb 24
Silexion, a Clinical-Stage, Oncology-Focused Biotechnology Company, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp
5:29pm
8-K
EX-10.2
8s5iv8y qyi88
26 Feb 24
Silexion, a Clinical-Stage, Oncology-Focused Biotechnology Company, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp
5:29pm
PRER14A
jdfu z2gc69fu67
24 Jul 23
Preliminary revised proxy
4:45pm
PRE 14A
cvapwkzutqs1as1
15 Dec 22
Preliminary proxy
5:18pm
425
EX-2.1
o6bsv9qj6 75dzi
13 Jun 22
Business combination disclosure
5:15pm
425
EX-10.4.1
39txf5c89x9tp16z
13 Jun 22
Business combination disclosure
5:15pm
8-K
EX-2.1
ixp2qkzn26cwf1
13 Jun 22
There’s always a better travel deal out there INVESTOR PRESENTATION JUNE 2022
5:12pm